The World Health Organization (WHO) published a priority pathogens list for research and development of new antibiotics in 2017. The list categorized pathogens into three priority levels: Priority 1 - Critical (Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae), Priority 2 - High (Enterococcus faecium, Staphylococcus aureus, Helicobacter pylori, Campylobacter spp., Salmonellae, Neisseria gonorrhoeae), and Priority 3 - Medium (Streptococcus pneumoniae, Haemophilus influenzae, Shigella spp.). The priority levels were based on antibiotic resistance threats and the need for new treatments.
Original Description:
WHO priority pathogens for R &D of new antibiotics 2017
The World Health Organization (WHO) published a priority pathogens list for research and development of new antibiotics in 2017. The list categorized pathogens into three priority levels: Priority 1 - Critical (Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae), Priority 2 - High (Enterococcus faecium, Staphylococcus aureus, Helicobacter pylori, Campylobacter spp., Salmonellae, Neisseria gonorrhoeae), and Priority 3 - Medium (Streptococcus pneumoniae, Haemophilus influenzae, Shigella spp.). The priority levels were based on antibiotic resistance threats and the need for new treatments.
The World Health Organization (WHO) published a priority pathogens list for research and development of new antibiotics in 2017. The list categorized pathogens into three priority levels: Priority 1 - Critical (Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae), Priority 2 - High (Enterococcus faecium, Staphylococcus aureus, Helicobacter pylori, Campylobacter spp., Salmonellae, Neisseria gonorrhoeae), and Priority 3 - Medium (Streptococcus pneumoniae, Haemophilus influenzae, Shigella spp.). The priority levels were based on antibiotic resistance threats and the need for new treatments.